Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-beta. Silk JD, Abbott RJM, Adams KJ, Bennett AD, et al. J Immunol 2022;208:169-180.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silk JD, Abbott RJM, Adams KJ, Bennett AD, et al. Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-beta. J Immunol 2022;208:169-180.
PMID: 34853077